Rescue antiemetic · adults and children having any type of surgical procedure under general anaesthesia, regional anaesthesia or sedation, as hospital…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
All‐cause mortality Median · adults older than 18 years, with no restriction regarding presence of ASCVD; participants generally had elevated risk of ASCVD (as…
The intervention showed no clear difference in all‐cause mortality Median (low certainty).
1 finding from 1 review
Intervention not reported
ASCVD event, such as fatal or non‐fatal myocardial infarction or stroke. Median · adults older than 18 years, with no restriction regarding presence of ASCVD; participants generally had elevated risk of ASCVD (as…
The intervention showed no clear difference in ASCVD event, such as fatal or non‐fatal myocardial infarction or… (low certainty).
1 finding from 1 review
Intervention not reported
Any investigator‐defined adverse event Median · adults older than 18 years, with no restriction regarding presence of ASCVD; participants generally had elevated risk of ASCVD (as…
The intervention probably leads to higher any investigator‐defined adverse event Median (moderate certainty).
1 finding from 1 review
Intervention not reported
Systolic blood pressure, mmHg Median · adults older than 18 years, with no restriction regarding presence of ASCVD; participants generally had elevated risk of ASCVD (as…
1 finding from 1 review
Intervention not reported
Total cholesterol, mmol/L Median · adults older than 18 years, with no restriction regarding presence of ASCVD; participants generally had elevated risk of ASCVD (as…
1 finding from 1 review
Intervention not reported
LDL cholesterol, mmol/L Median · adults older than 18 years, with no restriction regarding presence of ASCVD; participants generally had elevated risk of ASCVD (as…
1 finding from 1 review
Intervention not reported
Adherence, variable definitions Median · adults older than 18 years, with no restriction regarding presence of ASCVD; participants generally had elevated risk of ASCVD (as…
The intervention probably leads to higher adherence, variable definitions Median (moderate certainty).
1 finding from 1 review
Major limb amputation ( · Individuals with peripheral arterial disease
Growth factors showed no clear difference in major limb amputation ( compared with placebo or no therapy (moderate certainty).
1 finding from 1 review
Any limb amputation ( · Individuals with peripheral arterial disease
Growth factors may leads to lower any limb amputation ( compared with placebo or no therapy (low certainty).
1 finding from 1 review
Death ( · Individuals with peripheral arterial disease
Growth factors showed no clear difference in death ( compared with placebo or no therapy (moderate certainty).
1 finding from 1 review
Serious adverse events ( · Individuals with peripheral arterial disease
Growth factors showed no clear difference in serious adverse events ( compared with placebo or no therapy (moderate certainty).
1 finding from 1 review
Any adverse event ( · Individuals with peripheral arterial disease
Growth factors showed no clear difference in any adverse event ( compared with placebo or no therapy (moderate certainty).
1 finding from 1 review
Death · patients treated for H. influenzae meningitis
1 finding from 1 review
Adverse events considered non‐serious · participants with unresectable hepatocellular carcinoma
It is very uncertain whether adenovirus‐thymidine kinase with ganciclovir (ADV‐TK/GCV) plus liver… changes adverse events considered non‐serious (number of participants) compared with liver transplantation (very low certainty).
1 finding from 1 review
All‐cause mortality · participants with unresectable hepatocellular carcinoma
Double‐dose adenovirus‐thymidine kinase with ganciclovir… may leads to lower all‐cause mortality compared with liver transplantation (low certainty).
1 finding from 1 review
Proportion of people with ≥ 1 serious adverse events during treatment · participants with unresectable hepatocellular carcinoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health‐related quality of life · participants with unresectable hepatocellular carcinoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Disease progression · participants with unresectable hepatocellular carcinoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events considered non‐serious · participants with unresectable hepatocellular carcinoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found